Structure

InChI Key SHGAZHPCJJPHSC-XFYACQKRSA-N
Smile CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1
InChI
InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14-

Physicochemical Descriptors

Property Name Value
Molecular Formula C20H28O2
Molecular Weight 300.44
AlogP 5.6
Hydrogen Bond Acceptor 1.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 5.0
Polar Surface Area 37.3
Molecular species ACID
Aromatic Rings 0.0
Heavy Atoms 22.0

Pharmacology

Action Mechanism of Action Reference
AGONIST Retinoic acid receptor agonist PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Lung Neoplasms 3 D008175 ClinicalTrials
Brain Neoplasms 3 D001932 ClinicalTrials
Severe Acute Respiratory Syndrome 3 D045169 ClinicalTrials
Central Nervous System Neoplasms 3 D016543 ClinicalTrials
Neuroblastoma 3 D009447 ClinicalTrials
Medulloblastoma 3 D008527 ClinicalTrials
Kidney Neoplasms 3 D007680 ClinicalTrials
Head and Neck Neoplasms 3 D006258 ClinicalTrials
Uterine Cervical Dysplasia 3 D002578 ClinicalTrials
Rosacea 3 D012393 ClinicalTrials
Keratosis, Actinic 2 D055623 ClinicalTrials
Glomerulosclerosis, Focal Segmental 2 D005923 ClinicalTrials
Leukemia, Myelomonocytic, Juvenile 2 D054429 ClinicalTrials
Mycosis Fungoides 2 D009182 ClinicalTrials
Leukemia 2 D007938 ClinicalTrials
Tinea Pedis 2 D014008 ClinicalTrials
Azoospermia 2 D053713 ClinicalTrials
Emphysema 2 D004646 ClinicalTrials
Ganglioneuroblastoma 2 D018305 ClinicalTrials
Klinefelter Syndrome 2 D007713 ClinicalTrials
HIV Infections 2 D015658 ClinicalTrials
Multiple Myeloma 2 D009101 ClinicalTrials
Uterine Cervical Neoplasms 2 D002583 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 2 D064129 ClinicalTrials
Ichthyosis 2 D007057 ClinicalTrials
Oligodendroglioma 1 D009837 ClinicalTrials
Infections 1 D007239 ClinicalTrials
Alzheimer Disease 1 D000544 ClinicalTrials
Hodgkin Disease 1 D006689 ClinicalTrials
Myelodysplastic Syndromes 1 D009190 ClinicalTrials
Leukemia, Myeloid, Acute 1 D015470 ClinicalTrials
Leukemia, Promyelocytic, Acute 1 D015473 ClinicalTrials
Burkitt Lymphoma 1 D002051 ClinicalTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 D015464 ClinicalTrials
Lymphoma, Large B-Cell, Diffuse 1 D016403 ClinicalTrials
Glioblastoma 1 D005909 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Carcinoma, Renal Cell 1 D002292 ClinicalTrials
Astrocytoma 1 D001254 ClinicalTrials
Oligodendroglioma 1 D009837 ClinicalTrials
Epidermolysis Bullosa 1 D004820 ClinicalTrials
Gliosarcoma 1 D018316 ClinicalTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 D054198 ClinicalTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 D054198 ClinicalTrials
Glioma 1 D005910 ClinicalTrials

Related Entries

MCS

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Gastrointestinal disorders
21.38
Psychiatric disorders
14.89
Skin and subcutaneous tissue disorders
7.66
Injury, poisoning and procedural complications
7.28
Immune system disorders
6.04
General disorders and administration site conditions
5.56
Investigations
5.29
Musculoskeletal and connective tissue disorders
5.11
Nervous system disorders
4.9
Vascular disorders
3.69
Pregnancy, puerperium and perinatal conditions
3.06
Respiratory, thoracic and mediastinal disorders
2.91
Infections and infestations
2.62
Eye disorders
2.08

Cross References

Resources Reference
CAS NUMBER 4759-48-2
ChEBI 6067
ChEMBL CHEMBL547
DrugBank DB00982
DrugCentral 1508
EPA CompTox DTXSID4023177
FDA SRS EH28UP18IF
Human Metabolome Database HMDB0006219
Guide to Pharmacology 7600
KEGG C07058
PDB REA
PubChem 5282379
SureChEMBL SCHEMBL38299
ZINC ZINC000003792789